Calcium Channel Blocker Market Size, Share, And Growth Report 2032

Calcium Channel Blocker Market

Calcium Channel Blocker Market By Drug Class (Dihydropyridine And Non-Dihydropyridine), By Application (Hypertension, Angina Pectoris, Pregnancy, Obesity And Other), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024-2032

Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-717 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 15.19 Billion USD 25.19 Billion 5.78% 2023

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Drugs Class
        • 2.1.1.2. Market Attractiveness Analysis, By Application
      • 2.1.1.3 Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Calcium Channel Blocker Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Calcium Channel Blocker Market – Application Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Drugs Class, 2020 & 2028
    • 4.2. Dihydropyridine
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.2.4 Amuldipine
      • 4.2.4.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.5 Cilnidipine
      • 4.2.5.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.6 Felodipine
      • 4.2.6.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.7 Isradipine
      • 4.2.7.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.8 Nicardipine
      • 4.2.8.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.9 Nisuldipine
      • 4.2.9.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.10 Nifedipine
      • 4.2.10.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.2.11 Others
      • 4.2.11.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Non-Dihydropyridine
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3.4 Diltiazem
      • 4.3.4.1 Key Market Trends, Growth Factors, & Opportunities
    • 4.3.5 Verapamil
      • 4.3.5.1 Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Calcium Channel Blocker Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Angina Pectoris
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Hypertension
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Pregnancy
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Obesity
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Others
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Calcium Channel Blocker Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Drug Class, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Drug Class, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Drug Class, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Drug Class, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Drug Class, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Drug Class, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Drug Class, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Drug Class, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Drug Class, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Drug Class, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Drug Class, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Drug Class, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Drug Class, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Drug Class, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Calcium Channel Blocker Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2020
      • 8.1.1. Global Calcium Channel Blocker Market: Company Market Share, 2020
      • 8.1.2. Global Calcium Channel Blocker Market, Company Market Revenue, 2017 – 2020 (USD Billion)
      • 8.1.3. Global Calcium Channel Blocker Market, Company Y-o-Y Growth, 2017 – 2020(%)
      • 8.1.4. Global Calcium Channel Blocker Market: Radar Determinant Chart, 2020
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Pfizer Inc
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Astazenca Plc
    • 9.3. Bayer Healthcare LLC.
    • 9.4. GlaxoSmithKline plc
    • 9.5. Johnson & Johnoson
    • 9.6. Abcam
    • 9.7. AbMule Bioscience
    • 9.8. Clearsynth
    • 9.9. Sanofi S. A.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Drug Class
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Calcium Channel Blocker Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5 Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Drug Class, 2020 & 2028
FIG NO. 7. Global Calcium Channel Blocker Market for Dihydropyridine, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Calcium Channel Blocker Market for Dihydropyridine, By Country, 2020 & 2028
FIG NO. 9. Global Calcium Channel Blocker Market for Non-Dihydropyridine, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Calcium Channel Blocker Market for Non-Dihydropyridine, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 12. Global Calcium Channel Blocker Market for Hypertension, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Calcium Channel Blocker Market for Hypertension, By Country, 2020 & 2028
FIG NO. 14. Global Calcium Channel Blocker Market for Angina pectoris, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Calcium Channel Blocker Market for Angina pectoris, By Country, 2020 & 2028
FIG NO. 16. Global Calcium Channel Blocker Market for Pregnancy, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Calcium Channel Blocker Market for Pregnancy, By Country, 2020 & 2028
FIG NO. 18. Global Calcium Channel Blocker Market for Obesity, Revenue (USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Calcium Channel Blocker Market for Obesity, By Country, 2020 & 2028
FIG NO. 20. Global Calcium Channel Blocker Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Calcium Channel Blocker Market for Others, By Country, 2020 & 2028
FIG NO. 22. Global Calcium Channel Blocker Market Revenue Share, By Region, 2020 & 2028
FIG NO. 23. North America Calcium Channel Blocker Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 24. Porter’s Five Forces Analysis for Global Calcium Channel Blocker Market
FIG NO. 25. PEST Analysis for Global Calcium Channel Blocker Market
FIG NO. 26. Pricing Analysis for Global Calcium Channel Blocker Market
FIG NO. 27. Value Chain Analysis for Global Calcium Channel Blocker Market
FIG NO. 28. Company Share Analysis, 2019
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. Pfizer Inc Business Segment Revenue Share, 2020 (%)
FIG NO. 32. Pfizer Inc Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Product, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Calcium Channel Blocker Market: Snapshot
TABLE NO. 2. Quarterly Calcium Channel Blocker Market Revenue by Region, 2020
TABLE NO. 3 Quarterly Calcium Channel Blocker Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Calcium Channel Blocker Market for Dihydropyridine, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Calcium Channel Blocker Market for Non-Dihydropyridine, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Calcium Channel Blocker Market for Hypertension, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Calcium Channel Blocker Market for Angina pectoris, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Calcium Channel Blocker Market for Pregnancy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Calcium Channel Blocker Market for Obesity, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Calcium Channel Blocker Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Calcium Channel Blocker Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. North America Calcium Channel Blocker Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 15. North America Calcium Channel Blocker Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 16. North America Calcium Channel Blocker Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 17. U.S. Calcium Channel Blocker Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 18. U.S. Calcium Channel Blocker Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 19. Canada Calcium Channel Blocker Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 20. Canada Calcium Channel Blocker Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 21. Mexico Calcium Channel Blocker Market Revenue, By Drug Class, 2016 – 2028 (USD Billion)
TABLE NO. 22. Mexico Calcium Channel Blocker Market Revenue, By Application, 2016 – 2028 (USD Billion)
TABLE NO. 23. Drivers for the Calcium Channel Blocker Market: Impact Analysis
TABLE NO.24. Restraints for the Calcium Channel Blocker Market: Impact Analysis
TABLE NO. 25. Major Buyers of Calcium Channel Blocker
TABLE NO. 26. Distributors/Traders List of Calcium Channel Blocker  
TABLE NO. 27. Global Calcium Channel Blocker Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 28. Global Calcium Channel Blocker Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)

Methodology

FrequentlyAsked Questions

Calcium channel blockers (CCBs) are medications that relax and widen blood vessels by inhibiting calcium from entering the muscle cells of the heart and blood vessel walls. They are commonly used to treat conditions like high blood pressure, angina, and certain heart rhythm disorders.

According to study, the Calcium Channel Blocker Market size was worth around USD 15.19 billion in 2023 and is predicted to grow to around USD 25.19 billion by 2032.

The CAGR value of Calcium Channel Blocker Market is expected to be around 5.78% during 2024-2032.

North America has been leading the Calcium Channel Blocker Market and is anticipated to continue on the dominant position in the years to come.

The Calcium Channel Blocker Market is led by players like Pfizer Inc., AstraZeneca Plc., Bayer Healthcare LLC., GlaxoSmithKline Plc., Sanofi S.A., Johnson & Johnson, Abcam, AbMole Bioscience, and Clearsynth.

Choose License Type

  • zion payment modes

List of Contents

Market SizeOverviewCOVID-19 Impact AnalysisGrowth FactorsSegmentationReport ScopeRegional AnalysisCompetitive PlayersThe global Market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed